Vice President, Global Commercial Development Disease Area Lead jobs in United States
cer-icon
Apply on Employer Site
company-logo

Revolution Medicines · 2 weeks ago

Vice President, Global Commercial Development Disease Area Lead

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Vice President, Global Commercial Development Disease Area Lead will lead global oncology marketing capabilities, focusing on disease area strategy, launch strategy, and lifecycle planning while collaborating across various teams to drive successful commercialization efforts.

Health CareLife ScienceMedical

Responsibilities

Partner across the company including with clinical development, medical affairs, market access, to drive disease area strategy, shape brand strategies across disease area leadership team and product teams
Ensure global readiness to drive successful launch planning, commercialization, and performance tracking across the U.S. and key ex-U.S. markets
Lead a team to design and execute global disease area strategy, brand strategies, including branding, positioning, messaging, and value propositions that guide regional affiliates and align with long-term portfolio goals
Translate scientific and market insights into compelling strategies, launch narratives, and execution plans; effectively communicating recommendations and leading strategic discussions with global and regional stakeholders
Develop and refine global brand plans, including revenue and patient forecasts, to inform investment decisions, lifecycle strategies, and portfolio prioritization
Partner with Marketing, Sales, Market Access, and Medical Affairs to align on integrated brand planning, optimize execution across touchpoints, and ensure consistent messaging worldwide
Drive excellence in global launch execution: creating launch frameworks, ensuring best practices are shared across affiliates, and monitoring progress to anticipate and resolve challenges
Identify and manage external agencies, vendors, and partners to deliver impactful global campaigns, educational initiatives, and engagement platforms
Serve as a trusted resource to executive leadership in identifying opportunities to maximize commercial value, expand indications, and differentiate in competitive markets
Bring innovation and new capabilities to global marketing—collaborate with IS Commercial to integrate digital, omnichannel, and data-driven approaches to build a best-in-class commercial function
Provide coaching to lead and develop direct reports to become a highly effective team
Up to 50% of travel required

Qualification

Global marketing strategyOncology launch experienceCross-functional leadershipCommercial experienceData-driven marketingEntrepreneurial mindsetInterpersonal skillsOrganizational skills

Required

Bachelor's degree required (MBA preferred) with at least 15+ years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and ideally sales
Proven success of developing and executing global marketing strategy
Experience in leading the global launch of new product in competitive spaces
Demonstrated ability to derive insights/analytics leading to the development of innovative marketing strategies
Strong leadership, with the ability to lead teams, work well cross-functionally, and influence across the organization to create a clear sense of direction
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients

Preferred

Experience with an oncology launch is desired
Prior experience in a smaller, rapidly growing, company
Experience in gastrointestinal or lung cancers preferred

Benefits

Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities

Company

Revolution Medicines

twittertwitter
company-logo
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Funding

Current Stage
Public Company
Total Funding
$2.25B
Key Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M

Leadership Team

leader-logo
Luan Wilfong
Chief Human Resources Officer
linkedin
leader-logo
Steve Kelsey
President
linkedin
Company data provided by crunchbase